This study supported that the knockdown of lncRNA Kcnq1ot1 inhibited inflammation in AKI by blocking the sponging to miR-204-5p and limiting the activation of the NLRP3 inflammasome, and thus provided potential molecular targets for AKI treatment. Here, NLRP3 is linked to acute kidney injury.